针对抗菌活性和超级炎症缓解的四重化胆固醇.
Dipanjana Patra1,2, Sayan Chakravarty2, Himani Singh2
1Chemistry and Physics of Materials Unit, Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR), Jakkur, Bengaluru, Karnataka 560064, India.
ACS infectious diseases
|February 25, 2026
概括
一种新型的四分制硫化聚合物 (QTP) 有效地对抗耐药细菌和生物膜. 这种广泛的抗菌剂还可以减少炎症并促进伤口愈合,为具有挑战性的感染提供了有希望的解决方案.
科学领域:
- 生物材料科学 生物材料科学
- 聚合物化学 聚合物化学
- 传染性疾病 传染性疾病
背景情况:
- 越来越多的感染和有限的抗菌选择需要新的广泛的治疗方法.
- 超级细菌形成弹性生物膜,使感染控制复杂化.
- 基托桑衍生物显示出有前途,但协同作用的修改尚未得到充分探索.
研究的目的:
- 合成和评估一种新型四分制硫化聚合物 (QTP).
- 研究QTP的协同抗菌和抗生物膜特性.
- 在伤口感染模型中评估QTP的疗效.
主要方法:
- 由HTCC和硫甘油酸合成的四度性硫化聚合物 (QTP).
- 对耐药细菌进行测试的广泛抗菌活性.
- 进行了抗氧化剂,毒性和生物膜抑制试验.
- 在小鼠表面伤口感染模型中评估有效性.
主要成果:
- QTP表现出针对格兰美阳性和格兰负性细菌的广泛活性.
- 该聚合物表现出抗氧化特性和低毒性.
- QTP显著降低了细菌生物膜 (>99.9%).
- 在体内,QTP消除了MRSA并促进了皮肤愈合.
结论:
- QTP提供了四级化和硫化的一种协同组合.
- 开发的聚合物呈现出对抗耐药细菌感染的强有力的治疗候选者.
- QTP显示出治疗复杂的伤口感染的潜力.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
646
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
646
Combined Effects of Drugs: Synergism
7.0K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
7.0K
Inflammatory Bowel Disease IV: Pharmacological Management
852
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
852
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
602
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
602
Gene Regulation in Microbial Communities: Quorum Sensing
762
Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
762
Antimicrobial Effectiveness
1.2K
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
1.2K


